#eccmid2023 — Public Fediverse posts

RT VACCELERATE Consortium 🇪🇺🇺🇦
#VACCELERATE: A European network for the development of #COVID19 vaccine #clinicaltrials and beyond: Interview with @KerstinAlbus at #ECCMID2023.
Interview and filming by @touchINFECTDIS.
https://www.youtube.com/watch?v=Pmlvmzi6NbA https://t.co/to1dgdm42F

🐦🔗: https://n.respublicae.eu/vaccelerate_eu/status/1671455343669280769

🆕 Episode of #Breakpoints

In this special LIVE podcast episode, Drs. Jason Pogue and Erin McCreary present from Making a Difference in Infectious Diseases (MAD-ID) and give a rundown of everything from some #ECCMID2023 late breakers to published RCTs to stewardship-focused papers.

Have no fear: this episode is a COVID-free zone 😎
Listen now: https://sidp.pinecast.co/

🆕 Episode of #Breakpoints

In this special LIVE podcast episode, Drs. Jason Pogue and Erin McCreary present from Making a Difference in Infectious Diseases (MAD-ID) and give a rundown of everything from some #ECCMID2023 late breakers to published RCTs to stewardship-focused papers.

Have no fear: this episode is a COVID-free zone 😎
Listen now: https://sidp.pinecast.co/

🆕 Episode of #Breakpoints

In this special LIVE podcast episode, Drs. Jason Pogue and Erin McCreary present from Making a Difference in Infectious Diseases (MAD-ID) and give a rundown of everything from some #ECCMID2023 late breakers to published RCTs to stewardship-focused papers.

Have no fear: this episode is a COVID-free zone 😎
Listen now: https://sidp.pinecast.co/

RT @ECDC_EU: ECDC is present at #ECCMID2023! Visit our booth B4-27 for a meet-and-greet with our experts:

➡️Aikaterini Mougkou (@KMougkou), Monday, 10:30–10:45
➡️Eeva Broberg (@broberg_e), Monday, 10:45–11:00
➡️Lucia Pastore Celentano, Monday, 15:45–16:00
➡️Vivian Leung, Tuesday, 10:45–11:00

🐦🔗: https://n.respublicae.eu/EMA_News/status/1647892201769189376

RT @ECDC_EU: ECDC is present at #ECCMID2023! Visit our booth B4-27 for a meet-and-greet with our experts:

➡️Aikaterini Mougkou (@KMougkou), Monday, 10:30–10:45
➡️Eeva Broberg (@broberg_e), Monday, 10:45–11:00
➡️Lucia Pastore Celentano, Monday, 15:45–16:00
➡️Vivian Leung, Tuesday, 10:45–11:00

🐦🔗: https://n.respublicae.eu/EMA_News/status/1647892201769189376

RT @ECDC_EU: Today ECDC Director Andrea Ammon participated in a session on measuring the changing threat of COVID-19 at #ECCMID2023.

Dr Ammon provided a European perspective on how the pandemic was assessed and how we can improve for future threats.

🐦🔗: https://n.respublicae.eu/EMA_News/status/1647892040385003522

RT @ECDC_EU: Today ECDC Director Andrea Ammon participated in a session on measuring the changing threat of COVID-19 at #ECCMID2023.

Dr Ammon provided a European perspective on how the pandemic was assessed and how we can improve for future threats.

🐦🔗: https://n.respublicae.eu/EMA_News/status/1647892040385003522

RT @vaccelerate_eu: Our #VACCELERATE topics for the #ECCMID2023 final spurt: #ResearchNurses, #MAK5, #VolunteerRegistry #BeTheMissingPiece.
We are looking forward to a lively exchange and an exciting last day!
@Fiona_Cologne @JuliaNacov @SalmantonGarcia

🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1647984774978338820

RT @vaccelerate_eu: For your day planning at #ECCMID2023 in Copenhagen tomorrow 👇.
We would be very happy to talk to you about #VACCELERATE, #COVID19, #clinicaltrials, our #VolunteerRegistry and the #SiteNetwork.
#BeTheMissingPiece
@VaccelerateCY @SalmantonGarcia @JuliaNacov

🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1647860729859416065

RT @vaccelerate_eu: Visiting #ECCMID2023 in Copenhagen, April 15th -18th?
Don't miss out on visiting us in the Poster Arena on 17th and 18th - Very excited to meet you in Denmark and looking forward to informing you about #VACCELERATE.
@EU_HaDEA

🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1646797179783184385

Aikaterini Mougkou, Expert Antimicrobial Resistance and Healthcare Associated Infections, holding a meet-and-greet session at the ECDC info stand at #ECCMID2023

🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1647946965991190528

Aikaterini Mougkou, Expert Antimicrobial Resistance and Healthcare Associated Infections, holding a meet-and-greet session at the ECDC info stand at #ECCMID2023

🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1647946965991190528

Today ECDC Director Andrea Ammon participated in a session on measuring the changing threat of COVID-19 at #ECCMID2023.

Dr Ammon provided a European perspective on how the pandemic was assessed and how we can improve for future threats.

🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1647886860281151490

Today ECDC Director Andrea Ammon participated in a session on measuring the changing threat of COVID-19 at #ECCMID2023.

Dr Ammon provided a European perspective on how the pandemic was assessed and how we can improve for future threats.

🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1647886860281151490

ECDC is present at #ECCMID2023! Visit our booth B4-27 for a meet-and-greet with our experts:

➡️Aikaterini Mougkou (@KMougkou), Monday, 10:30–10:45
➡️Eeva Broberg (@broberg_e), Monday, 10:45–11:00
➡️Lucia Pastore Celentano, Monday, 15:45–16:00
➡️Vivian Leung, Tuesday, 10:45–11:00

🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1647607484025126920

ECDC is present at #ECCMID2023! Visit our booth B4-27 for a meet-and-greet with our experts:

➡️Aikaterini Mougkou (@KMougkou), Monday, 10:30–10:45
➡️Eeva Broberg (@broberg_e), Monday, 10:45–11:00
➡️Lucia Pastore Celentano, Monday, 15:45–16:00
➡️Vivian Leung, Tuesday, 10:45–11:00

🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1647607484025126920

Ok, that's a wrap for #ECCMID2023. Time for me to head back to my own "Hotel d'Angleterre".

Excellent conference. Lots of learning, networking and, yes, even socialising! 🍻

Thank you to organisers and all friends and colleagues who've made conference so enjoyable this year! 👏

@ESCMID

Ok, that's a wrap for #ECCMID2023. Time for me to head back to my own "Hotel d'Angleterre".

Excellent conference. Lots of learning, networking and, yes, even socialising! 🍻

Thank you to organisers and all friends and colleagues who've made conference so enjoyable this year! 👏

@ESCMID

Ok, that's a wrap for #ECCMID2023. Time for me to head back to my own "Hotel d'Angleterre".

Excellent conference. Lots of learning, networking and, yes, even socialising! 🍻

Thank you to organisers and all friends and colleagues who've made conference so enjoyable this year! 👏

@ESCMID

Ok, that's a wrap for #ECCMID2023. Time for me to head back to my own "Hotel d'Angleterre".

Excellent conference. Lots of learning, networking and, yes, even socialising! 🍻

Thank you to organisers and all friends and colleagues who've made conference so enjoyable this year! 👏

@ESCMID

Ok, that's a wrap for #ECCMID2023. Time for me to head back to my own "Hotel d'Angleterre".

Excellent conference. Lots of learning, networking and, yes, even socialising! 🍻

Thank you to organisers and all friends and colleagues who've made conference so enjoyable this year! 👏

@ESCMID

@mackayim2022 very fair point.

I tried, but hard enough to live tweet to also live toot at the same time!

At conferences, the power of twitter's established network effect is amplified further as well. Even the part time viewers go there to discuss work presented, making principled avoidance of twitter an even more self-defeating exercise.
#ID #ECCMID23 #clinicians #scientists #ECCMID2023

@mackayim2022 very fair point.

I tried, but hard enough to live tweet to also live toot at the same time!

At conferences, the power of twitter's established network effect is amplified further as well. Even the part time viewers go there to discuss work presented, making principled avoidance of twitter an even more self-defeating exercise.
#ID #ECCMID23 #clinicians #scientists #ECCMID2023

@mackayim2022 very fair point.

I tried, but hard enough to live tweet to also live toot at the same time!

At conferences, the power of twitter's established network effect is amplified further as well. Even the part time viewers go there to discuss work presented, making principled avoidance of twitter an even more self-defeating exercise.
#ID #ECCMID23 #clinicians #scientists #ECCMID2023

@mackayim2022 very fair point.

I tried, but hard enough to live tweet to also live toot at the same time!

At conferences, the power of twitter's established network effect is amplified further as well. Even the part time viewers go there to discuss work presented, making principled avoidance of twitter an even more self-defeating exercise.
#ID #ECCMID23 #clinicians #scientists #ECCMID2023

@mackayim2022 very fair point.

I tried, but hard enough to live tweet to also live toot at the same time!

At conferences, the power of twitter's established network effect is amplified further as well. Even the part time viewers go there to discuss work presented, making principled avoidance of twitter an even more self-defeating exercise.
#ID #ECCMID23 #clinicians #scientists #ECCMID2023

#ECCMID2023 is highlighting that #Mastodon has a way to go to make itself known to Scientists and clinicians & scientist-clinicians in the infectious diseases area. 😬
#ID #ECCMID23 #clinicians #scientists

#ECCMID2023 is highlighting that #Mastodon has a way to go to make itself known to Scientists and clinicians & scientist-clinicians in the infectious diseases area. 😬
#ID #ECCMID23 #clinicians #scientists

#ECCMID2023 is highlighting that #Mastodon has a way to go to make itself known to Scientists and clinicians & scientist-clinicians in the infectious diseases area. 😬
#ID #ECCMID23 #clinicians #scientists

#ECCMID2023 is highlighting that #Mastodon has a way to go to make itself known to Scientists and clinicians & scientist-clinicians in the infectious diseases area. 😬
#ID #ECCMID23 #clinicians #scientists

#ECCMID2023 is highlighting that #Mastodon has a way to go to make itself known to Scientists and clinicians & scientist-clinicians in the infectious diseases area. 😬
#ID #ECCMID23 #clinicians #scientists

At #ECCMID2023 & interested in whether IL-6 is important in #TB?

If so, pop by & visit my poster P1063 12:00-13:30

Preprint of this work also available here, but always more enjoyable for a F2F chat! #ECCMID23 #tuberculosis
https://www.medrxiv.org/content/10.1101/2023.02.07.23285472v1

At #ECCMID2023 & interested in whether IL-6 is important in #TB?

If so, pop by & visit my poster P1063 12:00-13:30

Preprint of this work also available here, but always more enjoyable for a F2F chat! #ECCMID23 #tuberculosis
https://www.medrxiv.org/content/10.1101/2023.02.07.23285472v1

At #ECCMID2023 & interested in whether IL-6 is important in #TB?

If so, pop by & visit my poster P1063 12:00-13:30

Preprint of this work also available here, but always more enjoyable for a F2F chat! #ECCMID23 #tuberculosis
https://www.medrxiv.org/content/10.1101/2023.02.07.23285472v1

At #ECCMID2023 & interested in whether IL-6 is important in #TB?

If so, pop by & visit my poster P1063 12:00-13:30

Preprint of this work also available here, but always more enjoyable for a F2F chat! #ECCMID23 #tuberculosis
https://www.medrxiv.org/content/10.1101/2023.02.07.23285472v1

At #ECCMID2023 & interested in whether IL-6 is important in #TB?

If so, pop by & visit my poster P1063 12:00-13:30

Preprint of this work also available here, but always more enjoyable for a F2F chat! #ECCMID23 #tuberculosis
https://www.medrxiv.org/content/10.1101/2023.02.07.23285472v1

Fabulous overview by Paul Bastard on the role of type I IFN auto-antibodies in increasing risk to:
- severe #COVID19 (adults & children)
- severe #influenza
- yellow fever vaccine adverse events
- West Nile virus encephalitis (unpublished)

Exciting field #ECCMID2023

Fabulous overview by Paul Bastard on the role of type I IFN auto-antibodies in increasing risk to:
- severe #COVID19 (adults & children)
- severe #influenza
- yellow fever vaccine adverse events
- West Nile virus encephalitis (unpublished)

Exciting field #ECCMID2023

Fabulous overview by Paul Bastard on the role of type I IFN auto-antibodies in increasing risk to:
- severe #COVID19 (adults & children)
- severe #influenza
- yellow fever vaccine adverse events
- West Nile virus encephalitis (unpublished)

Exciting field #ECCMID2023

Fabulous overview by Paul Bastard on the role of type I IFN auto-antibodies in increasing risk to:
- severe #COVID19 (adults & children)
- severe #influenza
- yellow fever vaccine adverse events
- West Nile virus encephalitis (unpublished)

Exciting field #ECCMID2023

Fabulous overview by Paul Bastard on the role of type I IFN auto-antibodies in increasing risk to:
- severe #COVID19 (adults & children)
- severe #influenza
- yellow fever vaccine adverse events
- West Nile virus encephalitis (unpublished)

Exciting field #ECCMID2023

One of the highlights of #ECCMID2023 has also been the #architecture in Copenhagen

One of the highlights of #ECCMID2023 has also been the #architecture in Copenhagen

One of the highlights of #ECCMID2023 has also been the #architecture in Copenhagen

One of the highlights of #ECCMID2023 has also been the #architecture in Copenhagen

One of the highlights of #ECCMID2023 has also been the #architecture in Copenhagen

Net immunosuppreve effect in organ transplant recipients.

Important concept in susceptibility to infections #ECCMID2023

Net immunosuppreve effect in organ transplant recipients.

Important concept in susceptibility to infections #ECCMID2023

Net immunosuppreve effect in organ transplant recipients.

Important concept in susceptibility to infections #ECCMID2023